No financial amount has been disclosed.
“With this decisive operation, HealthHero-Qare becomes the leading European e-health group, currently serving more than 22 million patients and carrying out nearly 3 million teleconsultations per year,” the companies said.
“This transaction will allow Qare to accelerate its development and enrich its offering in France, while becoming the research and development center for new patient services for the group.”
“In addition, Qare will become the consumer brand for all of HealthHero’s services in Europe,” they added.
Qare experienced a “good growth” year 2020, in part due to the boom in telemedicine caused by the Covid-19 epidemic, and alone records “nearly a million teleconsultations”, it is recalled .